FDA OKs New High-Dose Naloxone Product for Opioid Overdose FDA OKs New High-Dose Naloxone Product for Opioid Overdose

ZIMHI from Adamis Pharmaceuticals is administered using a single-dose, prefilled syringe that delivers 5 mg of naloxone hydrochloride solution through intramuscular or subcutaneous injection.FDA Approvals
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Psychiatry News Alert Source Type: news